Literature DB >> 3125262

Surgical treatment of premalignant lesions of the oral mucosa.

P Vedtofte1, P Holmstrup, E Hjørting-Hansen, J J Pindborg.   

Abstract

Oral premalignant lesions were treated by surgical excision in 61 patients. Criteria for inclusion in the study were epithelial dysplasia varying from slight to carcinoma in situ, or a non-dysplastic lesion located sublingually or on the tongue. The clinical diagnosis of the treated lesions were: erythroplakia 10, erythroleukoplakia 15, nodular leukoplakia 9, verrucous leukoplakia 9, homogeneous leukoplakia 13, and lichen planus 5. The surgically created defects were closed by direct approximation of the wound edges in 25 patients, transposition by a local mucosal flap in 9, covered with a free mucosal graft in 3, and by a free split skin transplant in 24 patients. The patients have been followed for an average period of 3.9 years after the operation. A recurrence rate of 20% was found, and 3 carcinomas developed in the follow-up period. The importance of using a surgical technique permitting histological examination of the entire lesion was documented by the finding of 4 superficial carcinomas in the excision specimen, undiagnosed in the preoperative biopsy.

Entities:  

Mesh:

Year:  1987        PMID: 3125262     DOI: 10.1016/s0901-5027(87)80049-8

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  14 in total

1.  Oral premalignancy: new methods of detection and treatment.

Authors:  Ann Gillenwater; Vali Papadimitrakopoulou; Rebecca Richards-Kortum
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

Review 2.  Oral premalignant lesions: from a clinical perspective.

Authors:  Teruo Amagasa; Masashi Yamashiro; Narikazu Uzawa
Journal:  Int J Clin Oncol       Date:  2011-01-12       Impact factor: 3.402

3.  Different CO2 laser vaporization protocols for the therapy of oral precancerous lesions and precancerous conditions: a 10-year follow-up.

Authors:  Herbert Deppe; Thomas Mücke; Bettina Hohlweg-Majert; Wolfgang Hauck; Stefan Wagenpfeil; Frank Hölzle
Journal:  Lasers Med Sci       Date:  2011-03-31       Impact factor: 3.161

4.  Designing a Mucoadhesive ChemoPatch to Ablate Oral Dysplasia for Cancer Prevention.

Authors:  Xiaoqin Liu; Qian Li; Yang Wang; Madeleine Crawford; Parnit K Bhupal; Xiuqing Gao; Huan Xie; Dong Liang; Yi-Shing L Cheng; Xiaohua Liu; Robert Y L Tsai
Journal:  Small       Date:  2022-05-19       Impact factor: 15.153

5.  Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions.

Authors:  Martial Guillaud; Lewei Zhang; Catherine Poh; Miriam P Rosin; Calum MacAulay
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

6.  A review of the nonsurgical treatment of oral leukoplakia.

Authors:  Adriana Spinola Ribeiro; Patrícia Ribeiro Salles; Tarcília Aparecida da Silva; Ricardo Alves Mesquita
Journal:  Int J Dent       Date:  2010-02-23

7.  Prevalence of Carcinomatous Foci in Oral Leukoplakia: A Clinicopathologic Study of 546 Indian Samples.

Authors:  Divya Gopinath; Beena Valappil Thannikunnath; Salmanul Faris Neermunda
Journal:  J Clin Diagn Res       Date:  2016-08-01

8.  Photodynamic therapy for head and neck dysplasia and cancer.

Authors:  Nestor R Rigual; Krishnakumar Thankappan; Michele Cooper; Maureen A Sullivan; Thomas Dougherty; Saurin R Popat; Thom R Loree; Merrill A Biel; Barbara Henderson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-08

9.  Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.

Authors:  Jeff J Johnson; Daniel L Miller; Rong Jiang; Yueying Liu; Zonggao Shi; Laura Tarwater; Russell Williams; Rashna Balsara; Edward R Sauter; M Sharon Stack
Journal:  J Biol Chem       Date:  2016-02-02       Impact factor: 5.157

10.  Comparison of pain and swelling after removal of oral leukoplakia with CO₂ laser and cold knife: a randomized clinical trial.

Authors:  Pía López-Jornet; Fabio Camacho-Alonso
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.